U.S. Industrials Stock News

Broker interest in Par Pacific Holdings (PARR) has picked up after the company attracted attention as a favored pick in the refining and logistics space, helped by recent earnings outperformance and sector wide oil price volatility. See our latest analysis for Par Pacific Holdings. Par Pacific Holdings has seen strong share price momentum, with a 30 day share price return of 43.95% and a year to date share price return of 119.54%. The 1 year total shareholder return of 145.37% points to...

Quantinuum (QNT) has drawn fresh attention after appointing Robin Schulman as Chief Legal Officer and Rory O’Byrne as Chief People Officer, expanding its senior leadership team in the middle of an active year for the stock. See our latest analysis for Quantinuum. Against that backdrop, Quantinuum’s 1-day share price return of 1.03% contrasts with a 7-day share price return that declined 7.88% and a 30-day share price return that fell 30.09%. The year-to-date share price return is down 12.5%,...

Crane (CR) reports earnings after the bell today, putting investor attention on whether expected 22.7% year on year revenue growth and steady analyst estimates align with the company’s recent share price performance. See our latest analysis for Crane. Crane’s recent momentum has been strong, with a 27.26% 90 day share price return and a 5 year total shareholder return of 281.43%. Together, these figures suggest investors are reassessing its long term prospects as earnings approach. If you...

In Q2 2026, Riverwater Partners used its Micro Opportunities Strategy investor letter to highlight CRA International (NASDAQ: CRAI), disclosing a larger position after a first‑quarter compensation reset that it believes should support improved results. The letter argued that CRA International’s focus on profitable small businesses leaves its shares undervalued relative to consulting peers seen as beneficiaries of artificial intelligence trends. We’ll now examine how Riverwater Partners’...

On July 15, 2026, Skyward Specialty Insurance Group (SKWD) increased its equity buyback authorization by US$50 million to a total of US$100 million, a move that directly affects existing and prospective shareholders. See our latest analysis for Skyward Specialty Insurance Group. The buyback announcement comes after a strong run in Skyward Specialty Insurance Group's stock, with a 90 day share price return of 34.79% and a 3 year total shareholder return of 159.39%. This suggests momentum has...

Pennant Group (PNTG) is drawing fresh attention after commentary highlighted its limited free cash flow, a 6x net debt to EBITDA ratio, and a forward P/E of 29.4x, which shapes current market expectations. See our latest analysis for Pennant Group. Pennant Group's recent share price strength, including a 30 day share price return of 15.1% and a 1 year total shareholder return of 78.0%, points to building momentum as investors weigh its leveraged balance sheet and higher forward P/E...

Why the ACES consortium and Zee matter for Archer Aviation stock Archer Aviation (ACHR) has stepped into focus after forming America’s Consortium for Electric Skyways to build up to 250 eVTOL charging sites, alongside launching its Zee aviation intelligence platform for data driven airspace operations. For investors, these two announcements connect physical infrastructure with software capabilities. ACES targets charging coverage across major U.S. metro areas, while Zee aims to interpret busy...

Pegasystems Inc. recently reported past second-quarter 2026 results with revenue rising to US$420.72 million while net income and earnings per share fell compared with a year earlier. Alongside these mixed earnings, the company launched Pega Infinity 26, an AI suite promising predictable outcomes and flat-fee AI usage that may influence enterprise adoption decisions. Next, we’ll examine how the Pega Infinity 26 launch and its flat-fee AI model may reshape Pegasystems’ existing investment...

Warrior Met Coal has delivered very strong share price gains over the past five years, yet current valuation checks point to a more balanced picture rather than a clear bargain or clear overpricing. The stock has returned about 365.5% over five years, which puts pressure on the current price to be backed by durable earnings and cash flow. Future demand and pricing for Warrior Met Coal's products can support the current valuation, while any sustained pressure on coal markets or operating...

Chipotle Mexican Grill recently ran two large promotions: a $1 million “Water” Break burrito giveaway tied to an international soccer final, and a two-day National Avocado Day offer of free chips and guacamole with digital entrée purchases using code AVO2026. By blending high-engagement social media games with app-only rewards and event-based offers, Chipotle is using promotions to deepen digital relationships with both loyal fans and first-time international visitors. Next, we’ll examine...

Recently, Plug Power outlined its Project Quantum Leap operational turnaround, including asset sales and cost-cutting measures aimed at achieving positive adjusted EBITDA by Q4 2026, while intensifying lobbying in Washington to secure key US green hydrogen tax incentives. This combination of internal restructuring and policy-focused efforts highlights how Plug Power is trying to reshape its business model around more efficient operations and supportive regulation for green hydrogen. Now...

NIKE (NKE) is back in focus after notifying Chinese retail partners Topsports and Pou Sheng that most of their online distribution rights will end on January 1, 2027, raising fresh questions about future China revenue. See our latest analysis for NIKE. NIKE's latest China distribution decision comes after a challenging stretch for holders, with the share price down 33.41% year to date and the 1 year total shareholder return declining 45.36%. Shorter term moves have been mixed and suggest...

Forte Biosciences stock has delivered a very large gain over the past year, yet the broad valuation checks currently lean expensive rather than pointing to an obvious bargain. After such a sharp move, investors are weighing whether recent optimism already builds in much of the potential from the company’s pipeline. Forte Biosciences has returned very roughly 6x over the past year, which puts extra focus on whether the current price leaves much room for disappointment. The progress of FB102...

Earlier this week, The Bank of N.T. Butterfield & Son Limited reported second‑quarter 2026 results showing higher net interest income of US$95.61 million but lower quarterly net income of US$46.91 million year on year, alongside confirming a US$0.50 per share quarterly dividend. Over the first half of 2026, Butterfield grew net interest income and lifted earnings per share compared with the prior year, while also progressing acquisitions such as R&H Guernsey and agreeing to buy CIBC...

Coinbase Global (COIN) has drawn fresh investor attention after announcing that Chief People Officer Lawrence Brock plans to step down in August 2026, with Dominique Baillet expected to take over the role. See our latest analysis for Coinbase Global. At a share price of US$167.49, Coinbase Global has seen a 1-month share price return of 12.36% and a year to date share price decline of 29.19%, while the 1-year total shareholder return has fallen 55.86%. This contrasts with a 3-year total...

Procter & Gamble stock has delivered a 19.1% total return over the past 5 years, yet recent performance has been softer. This sits against valuation checks that currently point to upside potential based on intrinsic value estimates and market multiples. Over the past 5 years Procter & Gamble has returned 19.1%, which suggests shareholders have seen modest compounding rather than outsized gains over that period. Plans to expand manufacturing and exports in markets such as Egypt can support...

The Johnson & Johnson talc settlement, which could reach more than US$7b, is a reminder that legal overhangs can reshape the risk profile of even the largest healthcare stocks. With payouts pulled forward into 2027 and 2028 and future lawsuits still possible, investors are reassessing how litigation, cash flow timing, and balance sheet strength fit into a portfolio. This article looks at how that news connects to our Large Cap Healthcare Stocks screener and highlights 3 stocks that appear...

Pool (POOL) has drawn attention after its latest quarterly earnings and a fresh update on long running share repurchases. Together, these announcements give you new information about profitability and capital returns. See our latest analysis for Pool. Pool’s latest earnings and continued buybacks come after a tougher stretch for investors, with the share price at $184.61 and a 1-year total shareholder return that declined 41.29%, while the 5-year total shareholder return fell 58.52%. The...

Innodata recently reported record revenue growth and an upgraded earnings outlook, crediting surging demand for its AI data engineering and platform services from enterprise and large tech clients. This momentum reinforces Innodata’s positioning as a pure-play AI services provider with increasingly diversified revenue streams and deeper integration into customers’ AI workflows. We’ll now examine how Innodata’s record revenue performance and strengthened AI platform positioning influence its...

Intel stock has delivered a very large 1 year return while the valuation checks send a more muted signal, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to roughly fair value and the broader scorecard suggesting the shares are not a clear bargain. Over the past year, Intel has returned about 343.3%, which puts extra focus on whether that move is fully supported by the company’s cash flow profile and long term earnings power. Heavy investment and customer interest...

CleanSpark has delivered a very strong 133.4% return over the past three years, yet its current valuation checks and recent share price pullback leave investors questioning whether the stock now leans expensive rather than clearly mispriced in their favor. Over three years, CleanSpark has returned 133.4%, which puts recent share price weakness in context and raises the question of how much of the story is already priced in. The company’s pivot toward large scale AI focused data centers can...

In July 2026, Illumina announced that its Billion Cell Atlas alliance, originally launched with AstraZeneca, Merck, and Eli Lilly, had expanded to include three additional AI‑focused drug developers and surpassed 350 million sequenced cells across more than 200 disease‑relevant cell lines. This rapidly growing CRISPR-based dataset, targeting one billion cells and generating several petabytes of genomic data, could materially enhance Eli Lilly’s ability to uncover new drug targets and...

In early August 2026, Williams Companies is scheduled to report its June-quarter results, with Wall Street expecting higher year-over-year earnings and revenue based on current analyst estimates. Analysts’ Most Accurate Estimate sits above the Zacks Consensus Estimate, and a positive Earnings ESP of 7.95% highlights growing optimism around the upcoming release. Next, we’ll examine how this rising earnings optimism, reflected in the positive Earnings ESP, affects Williams Companies’ existing...

Oil prices just dropped more than 2% as U.S. Iran hostilities paused, and that shift in energy costs and geopolitical risk could matter for your portfolio. Lower fuel and transport costs can ease pressure on household budgets, which may support parts of the consumer discretionary sector, while ongoing Middle East risks keep uncertainty in the mix. This article looks at how that news links to a curated screener of larger consumer discretionary stocks from the US, UK, Canada, Australia, and New...